2020 Presentations

PHYSICIANS SYMPOSIUM

• EMERGING TREATMENT PARADIGMS IN MULTIPLE MYELOMA: TARGETING THE NEIGHBORHOOD AND BEYOND – Kenneth Anderson, MD
• STATE OF THE ART: 2020 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu E. Birhiray, MD. Chair
• INDY HEMATOLOGY REVIEW 2020 TOWNHALL: CASE PRESENTATION – Ruemu E. Birhiray, MD. Chair
• BAD BLOOD: TREATMENT OF COMPLIMENTINOPATHIES AND APLASTIC ANEMIA – Robert Brodsky, MD
• WHO, WHEN AND HOW TO TREAT: THE PARADOX OF WATCHING, TREATMENT AND RETREATMENT IN INDOLENT LYMPHOMAS IN 2020s – Bruce Cheson, MD, FACP, FAAS, FASCO
• HOW I TREAT: THE PRACTICE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 2020 – Richard Childs, MD, RADM, USPHS
• CHRONIC LYMPHOCYTIC LEUKEMIA: WHO, WHEN AND HOW TO TREAT IN 2020 – Steven Coutre, MD
• NOVEL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA: DRIVERS, CARS AND TARGETED THERAPY – Hagop Kantarjian, MD
• BENIGN HEMATOLOGY: CURRENT TREATMENT OF CYTOPENIAS AND COAGULOPATHIES – Craig Kessler, MD
• CURRENT TREATMENT STRATEGIES OF MYELOPROLIFERATIVE NEOPLASMS – Rami Komrokji, MD
• CHRONIC MYELOID LEUKEMIA: THERAPEUTIC GOALS AND MANAGING RESISTANCE – Richard Larson, MD
• ACUTE MYELOID LEUKEMIA: PROGNOSTICATION, TARGETING AND SEQUENCING THERAPIES – Charles Schiffer, MD
• AGGRESSIVE LYMPHOMAS – Sonali Smith, MD
• T. HOWARD LEE KEYNOTE LECTURE: IMMUNOTHERAPY HEMATOLOGIC MALIGNANCIES: THERAPEUTIC CELLULAR IMMUNOTHERAPY – Edward Stadtmauer, MD
• MYELODYSPLASTIC SYNDROME: WHAT IS NEW IN 2020? – Richard Stone, MD
• WALDENSTRÖM’S MACROGLOBULINEMIA: CHOOSING WISELY IN PROGNOSTICATION AND TREATMENT IN 2020 – Steven Treon, MD, MA, PhD, FACP, FRCP
• CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP – Co-Chair

NURSING SYMPOSIUM

• INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA – Bruce Cheson, MD, FACP, FAAS, FASCO
• CHRONIC LEUKEMIAS – Steven Coutre, MD
• MULTIPLE MYELOMA AND WALDENSTRÖM’S – Morie Gertz, MD
• BENIGN HEMATOLOGY AND COAGULOPATHY – Craig Kessler, MD
• MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS, PROGNOSTICATION AND TREATMENT OPTIONS – Rami Komrokji, MD
• MANAGEMENT OF LONG-TERM SURVIVORS OF HEMATOLOGIC MALIGNANCIES – Kristi Orbaugh, RN, MSN RNP, AOCN
• MANAGING DRUG INTERACTION WITH ORAL ONCOLYTICS IN THE MANAGEMENT OF HEMATOLOGIC MALIGNANCIES – David Reeves, PharmD, BCOP
• CURRENT THERAPY IN AGGRESSIVE B AND T CELL LYMPHOMAS: AN UPDATE – Sonali Smith, MD

EVENING WITH THE EXPERTS

• EMERGING THERAPIES FOR BLOOD DISEASES, CANCERS, AND LYMPHOMAS – Ruemu E. Birhiray, MD. Chair
• EMERGING TREATMENT PARADIGMS IN MULTIPLE MYELOMA: TARGETING THE NEIGHBORHOOD AND BEYOND – Kenneth Anderson, MD
• STEM CELL TRANSPLANTATION AND CAR THERAPY – Richard Childs, MD, RADM, USPHS
• MYELOPROLIFERATIVE DISORDERS – Rami Komrokji, MD
• AGGRESSIVE B AND T CELL LYMPHOMAS – Sonali Smith, MD
• WALDENSTRÖM’S MACROGLOBULINEMIA – Steven Treon, MD, MA, PhD, FACP, FRCP
• ART THERAPY AND YOU – Megan Wiggins, MA, LMHCA